Nepal Approves Emergency Use of COVID-19 Vaccines from India
[Asia Economy Reporter Kiho Sung] Nepal has approved the use of the novel coronavirus (COVID-19) vaccine developed by the multinational pharmaceutical company AstraZeneca.
According to local media on the 15th, the Nepalese government made the decision to grant emergency use authorization for the AstraZeneca COVID-19 vaccine (Covishield) produced in India.
Countries that have previously approved the use of the AstraZeneca vaccine include the United Kingdom, India, Argentina, and Bangladesh.
Hot Picks Today
600 Million vs. 460 Million vs. 160 Million... Samsung Electronics DS Division: "Three Paychecks Under One Roof"
- Opening a Bank Account in Korea Is Too Difficult..."Over 150,000 Won in Notarization Fees Just for a Child's Account and Debit Card" [Foreigner K-Finance Status]②
- "Disappointing Results: 80% of Sunscreens Found Lacking in Safety and Effectiveness"
- "Not Even Buying a Bottle of Water": BTS Fans Outraged Over Price-Gouging by Busan Accommodations
- "Who Is Visiting Japan These Days?" The Once-Crowded Tourist Spots Empty Out... What's Happening?
As of the day, Nepal's cumulative number of COVID-19 confirmed cases was reported at 266,816. The number of new confirmed cases has been reported at 300 to 500 per day recently.
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
!["Please Help Us": How Much Do Those Bowing Deeply for Your Vote Really Earn? [Data Pick]](https://cwcontent.asiae.co.kr/asiaresize/307/2026052010120870131_1779239528.png)
